EVR Research’s Omnicell OMCL Stock Holding History

EVR Research’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-173,000	Closed	-$5.77M	–	36
2026 Q1	$5.77M	Buy	+173,000	New	+$7.24M	2.31%	12

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

EVR Research's OMCL Position: Q2 2026 in Review

EVR Research sold out of Omnicell (OMCL) in Q2 2026, closing a stake of 173,000 shares — an estimated $5.77M sold.

EVR Research first reported a position in OMCL in Q1 2026 and held it in 1 quarter. The position peaked at $5.77M in Q1 2026. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

EVR Research reported no remaining Omnicell position as of Q2 2026 after selling out during the quarter.
EVR Research sold 173,000 Omnicell shares in Q2 2026, an estimated $5.77M.
EVR Research first reported a position in Omnicell in Q1 2026 and held it in 1 quarter.
EVR Research's Omnicell position peaked at $5.77M in Q1 2026.
306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on EVR Research's 13F filing for Q2 2026, filed 13 Aug 2026.